Factor I cleaves iC3b

Stable Identifier
R-HSA-3266557
Type
Reaction [transition]
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

Factor I (CFI) cleaves iC3b into two molecules, C3c, which is released into solution, and C3dg, which remains attached to the membrane. This cleavage requires Complement receptor type 1 (CR1), which serves a cofactor for CFI (Medof et al. 1982). iC3b and C3dg can bind CR2 (CD21) to enhance B-cell immunity (Tuveson et al.1991, Sarrias et al. 2001).

Literature References
PubMed ID Title Journal Year
6607952 Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g

Davis, AE, Harrison, RA, Lachmann, PJ

J. Immunol. 1984
2971659 Identification of the C3b receptor-binding domain in third component of complement

Becherer, JD, Lambris, JD

J. Biol. Chem. 1988
21788512 Unique structure of iC3b resolved at a resolution of 24 Å by 3D-electron microscopy

Alcorlo, M, Martínez-Barricarte, R, Fernández, FJ, Rodríguez-Gallego, C, Round, A, Vega, MC, Harris, CL, de Córdoba, SR, Llorca, O

Proc. Natl. Acad. Sci. U.S.A. 2011
Participants
Participant Of
Catalyst Activity
Catalyst Activity
Title
serine-type endopeptidase activity of CFI [extracellular region]
Physical Entity
Activity
Orthologous Events
Authored
Reviewed
Created